Yakira Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-49,999
Closed -$2.8K – 405
2023
Q3
$2.8K Hold
49,999
– – ﹤0.01% 323
2023
Q2
$6.97K Hold
49,999
– – ﹤0.01% 269
2023
Q1
$4.25K Hold
49,999
– – ﹤0.01% 326
2022
Q4
$2.3K Hold
49,999
– – ﹤0.01% 343
2022
Q3
$7K Hold
49,999
– – ﹤0.01% 380
2022
Q2
$7K Buy
+49,999
New +$9.33K ﹤0.01% 385

Yakira Capital Management's BIOSW Position: Q4 2023 in Review

Yakira Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 49,999 shares — an estimated $2.8K sold.

Yakira Capital Management first reported a position in BIOSW in Q2 2022 and held it in 6 quarters. The position peaked at $7K in Q3 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Yakira Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Yakira Capital Management sold 49,999 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $2.8K.
  • Yakira Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 6 quarters.
  • Yakira Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $7K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Yakira Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.